EZH2 inhibition could be the key in treating Type 1 and Type 2 diabetes

28 Jul 2022

A new study published in Signal Transduction and Targeted Therapy has identified a pathway to the regeneration of insulin in pancreatic stem cells, with the inhibition of pancreatic EZH2 having restored progenitor insulin in a donor with Type 1 diabetes, research suggests.

News Medical

Hormones in the News